Investor Presentation • Jul 30, 2024
Investor Presentation
Open in ViewerOpens in native device viewer

De conformidad con lo establecido en el artículo 227 del texto refundido de la Ley del Mercado de Valores aprobado por el Real Decreto Legislativo 4/2015, de 23 de octubre, Inmobiliaria Colonial, SOCIMI, S.A. ("Colonial" o la "Sociedad") comunica la siguiente
Como continuación a la comunicación de información relevante publicada con fecha 29 de julio de 2024 con número de registro 29919, Colonial remite documentación de soporte a la presentación a analistas e inversores relativa a los resultados correspondientes al segundo trimestre de 2024, que se celebrará hoy martes día 30 de julio de 2024 a las 18:30 horas (CET) a través de un webcast.
Los datos de conexión a la conferencia se detallan a continuación:
España: +34 917 91 85 80 R. Unido: +44 020 3428 1388 Francia: +33 172 00 1700 Alemania: +49 891 436 7081 Holanda: +31 20 795 2680 USA: + 1 917 444 9040
Conference ID: 345632
La presentación podrá seguirse en tiempo real, vía webcast con audioconferencia a través del siguiente enlace:
Inmobiliaria Colonial – First Half 2024 Results Presentation
Adicionalmente, la presentación de resultados estará disponible en la página web de la Sociedad.
En Madrid, a 30 de julio de 2024
Colonial
July 30th, 2024
Top 1.5% Global
#1
1H 2024 RESULTS | 1
By attending this presentation and receiving this document, you are agreeing to be bound by the following limitations. Any failure to comply with these restrictions may constitute a violation of applicable securities laws and/or may result in civil, administrative or criminal liabilities.
This document is strictly confidential and is being furnished to you solely for your information. It may not be reproduced, or redistributed to any other person, and it may not be published, in whole or in part, for any purpose.
The information contained in this presentation ("Presentation") has been prepared by Inmobiliaria Colonial, SOCIMI S.A. (the "Company") and has not been independently verified and will not be updated. No representation, warranty or undertaking, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein and nothing in this Presentation is, or shall be relied upon as, a promise or representation. None of the Company nor any of its employees, officers, directors, advisers, representatives, agents or affiliates shall have any liability whatsoever (in negligence or otherwise, whether direct or indirect, in contract, tort or otherwise) for any loss howsoever arising from any use of this Presentation or its contents or otherwise arising in connection with this Presentation.
This Presentation is for information purposes only and is incomplete without reference to, and should be viewed solely in conjunction with, the oral briefing provided by the Company and the Company's publicly available information. The information and opinions in this presentation are provided as at the date hereof and subject to change without notice. It is not the intention to provide, and you may not rely on these materials as providing, a complete or comprehensive analysis of the Company's financial or trading position or prospects.
This Presentation does not constitute investment, legal, accounting, regulatory, taxation or other advice and does not take into account your investment objectives or legal, accounting, regulatory, taxation or financial situation or particular needs. You are solely responsible for forming your own opinions and conclusions on such matters and for making your own independent assessment of the Company. You are solely responsible for seeking independent professional advice in relation to the Company. No responsibility or liability is accepted by any person for any of the information or for any action taken by you or any of your officers, employees, agents or associates on the basis of such information.
This Presentation contains financial information regarding the businesses and assets of the Company. Such financial information may not have been audited, reviewed or verified by any independent accounting firm. The inclusion of such financial information in this Presentation or any related presentation should not be regarded as a representation or warranty by the Company, its affiliates, advisors or representatives or any other person as to the accuracy or completeness of such information's portrayal of the financial condition or results of operations by the Company and should not be relied upon when making an investment decision. . Certain financial and statistical information in this document has been subject to rounding off adjustments. Accordingly, the sum of certain data may not conform to the expressed total.
Certain statements in this Presentation are forward-looking. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions which could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These include, among other factors, changing economic, business or other market conditions, changing political conditions and the prospects for growth anticipated by the Company's management. These and other factors could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this Presentation and based upon past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
The market and industry data and forecasts included in this Presentation were obtained from internal surveys, estimates, experts and studies, where appropriate as well as external market research, publicly available information and industry publications. The Company, it affiliates, directors, officers, advisors and employees have not independently verified the accuracy of any such market and industry data and forecasts and make no representations or warranties in relation thereto. Such data and forecasts are included herein for information purposes only. Accordingly, undue reliance should not be placed on any of the industry or market data contained in this Presentation.
NEITHER THIS DOCUMENT NOR ANY OF THE INFORMATION CONTAINED HEREIN CONSTITUTES AN OFFER OF PURCHASE, SALE OR EXCHANGE, NOR A REQUEST FOR AN OFFER OF PURCHASE, SALE OR EXCHANGE OF SECURITIES, OR ANY ADVICE OR RECOMMENDATION WITH RESPECT TO SUCH SECURITIES.

03 Portfolio
Management
Future 04 Growth
01 Highlights
Two separate markets within the sector with different fundamentals
Our Market: Prime property with unique demand & supply characteristics
Our portfolio: Top-quality prime assets in central urban areas delivering superior performance
01 Highlights


2. Signed rents vs. previous contracts & re-let spaces
5. LTV including transfers costs as of 30.06.24 + impact of Criteria Caixa capital increase and the final execution of Méndez Álvaro Residential disposal. EPRA LTV post Alpha X stands at 44.2%

01 Highlights



01 Highlights




Gross rental income growth on the back of core portfolio & project deliveries

1) Like-for-like calculated following EPRA BPR recommendations
+12%
Solid Gross Rental Income like for like growth through superior pricing power



(1) In Spain consultants publish gross yields whereas in France consultants publish net yields
(2) In France, capital value corresponds to operating assets excluding the main commercial assets






at each corresponding date
1Includes cash inflows from Criteria and final settlement of asset disposals
2Colonial's Net Debt excluding debt attributable to projects divided by Topped up Operating EBITDA



Note: Current and future Spot Interest Rate estimate based on current drawn debt position not including additional funding/ debt.



03 Portfolio
Management
Our premium assets deliver strong letting performance…


… outperforming the market in every city


Signed rents vs previous contracts and re-let spaces
Signed rents vs 12/23 ERV (new lettings & renewals)

Additional rental growth & Capital Value
High Rental Increase
€19m New Rents >8% Yield On cost
Almost Delivered
2H 2024 Delivery
€15m Pending Capex
Strong commercial interest prior to delivery
Large Scale Project
56,000sqm Office
4,000 sqm Retail
Commercial Momentum
c.25% GLA Signed Head of Terms >150,000 sqm High Interest for large demands
Strong momentum



(1) Colonial ranks among the 26 companies with the highest rating out of 15,536 companies covered worldwide
(2) Only 346 companies out of 23,000 in the world have an "A" rating


Future 04 Growth
We delivered strong EPS growth on the back of a multi-layer growth platform

1 Excluding the impact of disposals



1. Based on last reported figures of 5 companies in the Euro area



Companies' Real Estate decisions based on a positive and enriching user experience



Premium Commercial

Premium Business Campus




Scope Business Campus

Sancho de Ávila Life Science/ Healthcare
Alpha X Project pipeline - Colonial's new source of growth




Sancho de Ávila Life Science/ Healthcare

Occupancy 70% Visionary at 50% €5.400/ sqm Capital Value

93%
Occupancy €2.992/ sqm Capital Value

Significant Rental Growth & Value creation Potential

Significant Rental Growth & Value creation Potential
Short term efficient renovation program

1ToppedUp Gross rental income as of 31/12/23
2Adjusted by Sta Hortensia, Condorcet (rents in place until 01/25) & Haussmann (rents in place until 6/24) – details see appendix
3Includes contributed Criteria assets, Diagonal 197 & Haussmann






15,000 sqm


We deliver profitable growth through premium space in prime locations


https://www.inmocolonial.com/en/shareholders-and-investors

1H 2024 RESULTS | 39
| - €m Results analysis |
1H 2024 |
1H 2023 |
|---|---|---|
| Gross Rents |
192 | 183 |
| expenses(*) Net operating Overheads |
(7) (28) |
(5) (23) |
| Recurring EBITDA |
157 | 156 |
| financial Recurring result |
(41) | (46) |
| Income expense & others - recurring tax |
(6) | (5) |
| Minority interests - recurring |
(19) | (18) |
| Recurring Earnings |
92 | 87 |
| Change fair of in value assets & provisions |
(13) | (525) |
| financial Non-recurring result & MTM |
(3) | (1) |
| Income & others - non-recurring tax |
49 | 4 |
| Minority interests - non-recurring |
(39) | 89 |
| Profit attributable the Group to |
86 | (347) |
| Recurring Earnings - €m |
92 | 87 |
| Nosh (mm) | 539.6 | 539.6 |
| EPS recurring - Cts€/share |
17.0 | 16.1 |
| EPS cont. operations - Cts€/share |
17.0 | 15.5 |


+1% YoY
06/23 06/24

NET RENTAL INCOME
EPRA EARNINGS PER SHARE (EPS)
+5.6% YoY 16 17 06/23 06/24
One of the highest occupancy ratios in the sector thanks to its prime positioning


93%
100%
projec t
€4,892m 36.7%2
€2,570m
€425m
€2,995m
4.5 years
100% 1.74%3
1Excluding ECPs
2 Including sales commitments already formalized and sale commitment of Méndez Álvaro Residentia+ Criteria Caixa Capital increase in July 2024
3 Excluding formalization costs accrued over the life of debt.
> 9% ungeared IRR
> 13% levered2 IRR at NTA


| Project | Use | Delivery | GLA (sqm) |
Total €m1 Cost |
Ungeared IRR |
|---|---|---|---|---|---|
| Scope Paris City Center |
Business Campus |
2026 | 22.000 | 309 | > 9% |
| Sancho de Ávila Barcelona 22@ |
Life Science/ Healthcare |
2027 | 17.860 | 114 | > 7% |
| Condorcet Paris City Center |
Urban Mixed-Use |
2027 | 24.000 | 366 | >9% |
| Santa Hortensia Madrid City Center |
Urban Mixed-Use |
2028 | 46.928 | 237 | >9% |
| 110.788 | 1.026 | >9% |


Sancho de Ávila Life Science/ Healthcare

Core
1 Total Cost = Asset Value pre project + future Capex




1 Condorcet tenant leaves at 31/01/25 & Haussmann at 01/07/2024
2 Adjusted by Sta Hortensia, Condorcet & Haussmann
3 Includes contributed assets & Renovation Programs on Diagonal 197 & Haussmann

| Asset | Area | Price | GLA | Cap. Value | |
|---|---|---|---|---|---|
| 150 Champs-Elysées (4Q 2023) |
CBD | €1,000m | 18,000 sqm | €55,556sqm | |
| 101 Champs-Elysées (2Q 2023) |
CBD | €146m | 4,300 sqm | €34,000/sqm | |
| S | 10 Rue de Bassano (1Q 2024) |
CBD | €48m | 1,750 sqm | €27,429/sqm |
| RI A P |
21-23 Rue de la Ville l'Évêque (2Q 2024) |
CBD | €100m | 4,200 sqm | €23,810/sqm |
| 14-16 Rue Halevy (1Q 2024) |
CBD | €219m | 10,000 sqm | €21,429/sqm | |
| 119-121 Boulevard Haussmann (1Q 2024) |
CBD | €190m | 9,350 sqm | €20,321/sqm |
| Asset | Area | Price | GLA | Cap. Value | |
|---|---|---|---|---|---|
| D RI |
Francisco Gervás 10 (1Q 2024) |
City Center | €60m | 8,000 sqm | €7,475/sqm |
| D A M |
Batalla del Salado 5 (1Q 2024) |
City Center | €60m | 8,100 sqm | €7,407/sqm |
| Portal de l'Àngel 40 (4Q 2022) Includes Office & Retail Units |
City Center | €105m | 4,400 sqm | €23,683/sqm | |
| Diagonal 662 Transaction not completed Sale price as of publishing date (1Q 2023) |
CBD | €240m | 27,300 sqm | €8,791sqm | |
| A N O L E C R A |
Step Up (2Q 2022) |
22@ | €35m | 4,500 sqm | €7,777/sqm |
| B | Mile 22@ (3Q 2022) |
22@ | €250m | 35,000 sqm | €7,142/sqm |
| Pamplona 101 (2Q 2023) |
22@ | €31m | 4,500 sqm | €6,889/sqm | |
Source: public information, press and consultants


© 2024 Colonial www.inmocolonial.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.